Topics

Granules May Be Next Private Equity Target

23:42 EST 3 Dec 2019 | SCRIP

A recent focus on high-margin generic formulations, strong contract manufacturing business, and expected cash inflow from stake sales in joint...

      

Related Stories

 

Original Article: Granules May Be Next Private Equity Target

NEXT ARTICLE

More From BioPortfolio on "Granules May Be Next Private Equity Target"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...